← All diseases Muscles and connective tissue

Myotonic dystrophy

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (37)Meta-analysis (7)Treatment guideline (7)Systematic review (11)Randomized trial (7)Phase 3 study (5)Clinical trial (148)Review article (142)Early study (phase 1 or 2) (12)Case report (114)Laboratory or animal study (33)Commentary or editorial (59)Retracted publication (1) Studies currently recruiting participants only (33)

Filter

Publications and studies (1161)

• RNA-binding protein CELF6 is cell cycle regulated and controls cancer cell proliferation by stabilizing p21. (2019/09/18) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Autoimmune polyglandular disorders in myotonic dystrophy]. (2019/09/12) ♡
• Intrinsic Myogenic Potential of Skeletal Muscle-Derived Pericytes from Patients with Myotonic Dystrophy Type 1. (2019/09/12) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study. (2019/09/10) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An Overview of Circular RNAs and Their Implications in Myotonic Dystrophy. (2019/09/06) ♡
• 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. (2019/09/01) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2019/09/01) ♡
• Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1. (2019/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. RNA sequencing reveals abnormal LDB3 splicing in sudden cardiac death. (2019/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acute Pancreatitis Associated With Myotonic Dystrophy Type I. (2019/09/01) ♡
• Transplantation studies reveal internuclear transfer of toxic RNA in engrafted muscles of myotonic dystrophy 1 mice. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. What is in the Myopathy Literature? (2019/09/01) ♡
• DMPK is a New Candidate Mediator of Tumor Suppressor p53-Dependent Cell Death. (2019/09/01) ♡
• [Multiorgan manifestations in myotonic dystrophy type 1]. (2019/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Association of Sjögren's syndrome with myotonic dystrophy type 1. (2019/08/28) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Probenecid: An Oral Inotrope for End-Stage Heart Failure in a Case With Myotonic Dystrophy. (2019/08/21) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2019/08/20) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. (2019/08/20) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. (2019/08/20) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. (2019/08/20) ♡
• Training program-induced skeletal muscle adaptations in two men with myotonic dystrophy type 1. (2019/08/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mitigating RNA Toxicity in Myotonic Dystrophy using Small Molecules. (2019/08/17) ♡
• Correction to: Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease. (2019/08/15) ♡
• A New View of the T-Loop Junction: Implications for Self-Primed Telomere Extension, Expansion of Disease-Related Nucleotide Repeat Blocks, and Telomere Evolution. (2019/08/14) ♡
• Combination Treatment of Erythromycin and Furamidine Provides Additive and Synergistic Rescue of Mis-Splicing in Myotonic Dystrophy Type 1 Models. (2019/08/09) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Consensus-based care recommendations for adults with myotonic dystrophy type 2. (2019/08/01) ♡
• Deprivation of Muscleblind-Like Proteins Causes Deficits in Cortical Neuron Distribution and Morphological Changes in Dendritic Spines and Postsynaptic Densities. (2019/07/30) ♡
• Global Increase in Circular RNA Levels in Myotonic Dystrophy. (2019/07/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Case Report of Myotonic Disease and Gastric Bypass and a Literature Review. (2019/07/01) ♡
• Ventricular tachycardia in patients with type 1 myotonic dystrophy: a case series. (2019/06/01) ♡
• Brugada syndrome in a young patient with type 1 myotonic dystrophy requiring an implantable cardioverter defibrillator for primary prevention: a case report. (2019/06/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Normalization of frequency-domain parameters of heart rate variability in patients with myotonic dystrophy. (2019/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Nodular morphea in a patient with Steinert disease. (2019/04/01) ♡
• Heart involvement in patients with myotonic dystrophy type 2. (2019/03/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Respiratory dysfunction in myotonic dystrophy type 1: A systematic review. (2019/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intellectual Disability: History Repeats Itself. (2019/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders. (2019/02/01) ♡
• Genotype-phenotype correlations in pediatric patients with myotonic dystrophy type 1. (2019/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Did You Examine the Parents? (2019/02/01) ♡
• Open-label trial of ranolazine for the treatment of paramyotonia congenita. (2019/02/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Cannabis use in myotonic dystrophy patients in Germany and USA: a pilot survey. (2019/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Understanding left ventricular hypertrabeculation/noncompaction: pathomorphologic findings and prognostic impact of neuromuscular comorbidities. (2019/02/01) ♡
• Pluripotent Stem Cell-Based Drug Screening Reveals Cardiac Glycosides as Modulators of Myotonic Dystrophy Type 1. (2019/01/25) ♡
• Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution. (2019/01/01) ♡
• Mir-206 partially rescues myogenesis deficiency by inhibiting CUGBP1 accumulation in the cell models of myotonic dystrophy. (2019/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. [Supraclavicular nerve and superior trunk block for surgical treatment of clavicle fracture in a patient with Steinert's disease - Case report]. (2019/01/01) ♡
• Structural white matter networks in myotonic dystrophy type 1. (2019/01/01) ♡
• Caregiver Burden and Related Factors Among Caregivers of Patients with Myotonic Dystrophy Type 1. (2019/01/01) ♡
• Texture analysis of sonographic muscle images can distinguish myopathic conditions. (2019/01/01) ♡
• Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1. (2019/01/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.